COP
Cosmo Pharma
Stock
Stock
ISIN: NL0011832936
Ticker: COPN
NL0011832936
COPN
Price
Price
CHART BY
Historical dividends and forecast
Cosmo Pharma has so far distributed $4.351 in 2024. The next dividend will be paid on 30.05.2025
$2.322
CHART BY
Frequently asked questions
What is Cosmo Pharma's market capitalization?
The market capitalization of Cosmo Pharma is 957.94M. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is Cosmo Pharma's Price-to-Earnings (P/E) ratio?
The Price-to-Earnings (P/E) ratio (TTM) for Cosmo Pharma is 14.37. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.
What is the Earnings Per Share (EPS) for Cosmo Pharma?
Cosmo Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $4.154. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Cosmo Pharma's stock?
Currently, 2 analysts cover Cosmo Pharma's stock, with a consensus target price of 112.87. Analyst ratings provide insights into the stock's expected performance.
What is Cosmo Pharma's revenue over the trailing twelve months?
Over the trailing twelve months, Cosmo Pharma reported a revenue of 178.04M.
What is the EBITDA for Cosmo Pharma?
Cosmo Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is 94.77M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Cosmo Pharma?
Cosmo Pharma has a free cash flow of 107.71M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Cosmo Pharma have, and what sector and industry does it belong to?
Cosmo Pharma employs approximately 325 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.
What is the free float of Cosmo Pharma's shares?
The free float of Cosmo Pharma is 7.09M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- 957.94M
- EPS (TTM)
- $4.154
- Free Float
- 7.09M
- P/E ratio (TTM)
- 14.37
- Revenue (TTM)
- 178.04M
- EBITDA (TTM)
- 94.77M
- Free Cashflow (TTM)
- 107.71M
Pricing
- 1D span
- $64.11$66.34
- 52W span
- $59.50$95.18
Analyst Ratings
The price target is 112.87 and the stock is covered by 2 analysts.
Buy
2
Hold
0
Sell
0
Information
Cosmo Pharmaceuticals NV engages in the development and manufacture of treatments and products for gastrointestinal diseases and dermatology. Its products include Lialda/Mezavant/Mesavancol, Uceris/Cortiment, Winlevi, GI Genius, Lumeblue, Aemcolo/Relafalk, Eleview, and Byfavo. The company was founded by Mauro Severino Ajani in 1997 and is headquartered in Dublin, Ireland.
- Employees
- 325
- Industries
- Pharmaceuticals: Major
- Sector
- Health Care
Identifier
- ISIN
- NL0011832936
- Primary Ticker
- COPN